WINNIPEG, Manitoba, July 21, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the Company or Kane Biotech), today announces that it has cancelled 8,470,555 stock options of the Company (the Cancelled Options) of various directors, officers,…
Kane Biotech Announces Cancellation of Options and Issuance of Restricted Share Units
Share this article
More News
Analysts see 15% upside on AI growth
October 12, 2026
What Investors Need To Know
October 12, 2026
Halifax
October 12, 2026